Global Health Program, Duke Kunshan University, Kunshan, Jiangsu, China.
Global Health Research Center, Duke Kunshan University, No.8 Duke Avenue, Kunshan, Jiangsu, China.
Curr Hypertens Rep. 2018 Aug 7;20(10):86. doi: 10.1007/s11906-018-0886-7.
This study aims to systematically review existing evidence on the effectiveness of mobile health technology (mHealth) interventions in addressing medication adherence among people with hypertension.
Twenty-one studies of mHealth interventions were included in the final review after systematic searching and screening of publications from 2000 to 2017 in PubMed, Web of Science, and Embase. Key features of the mHealth interventions include high intervention intensity, multifactorial components, and patient-centered approaches with tailored content and interaction. All studies found tendencies to improvement in medication adherence, but only 12 studies reported that the improvements were statistically significant in the intervention groups compared with the control groups. Twelve studies also found that mHealth interventions were beneficial for blood pressure control. None of the studies was conducted in a low-income country. Our systematic review found evidence that mHealth interventions improved medication adherence and blood pressure control among people with hypertension. However, most studies were small in sample size and short in study duration, and not all results were statistically significant. Future research should focus on investigating the sustainability and generalizability of mHealth interventions.
本研究旨在系统回顾现有关于移动医疗技术(mHealth)干预措施在提高高血压患者药物依从性方面效果的证据。
通过对 2000 年至 2017 年在 PubMed、Web of Science 和 Embase 发表的文献进行系统搜索和筛选,最终有 21 项 mHealth 干预措施的研究被纳入综述。mHealth 干预措施的主要特点包括干预强度高、多因素组成、以患者为中心的方法,以及针对特定内容和互动的定制化方法。所有研究都发现药物依从性有改善的趋势,但只有 12 项研究报告称与对照组相比,干预组的改善具有统计学意义。12 项研究还发现 mHealth 干预措施有益于控制血压。没有一项研究是在低收入国家进行的。我们的系统综述发现,mHealth 干预措施可提高高血压患者的药物依从性和血压控制水平。然而,大多数研究的样本量较小,研究持续时间较短,并非所有结果均具有统计学意义。未来的研究应集中于调查 mHealth 干预措施的可持续性和普遍性。